U.S. markets open in 4 hours 7 minutes
  • S&P Futures

    4,197.75
    +3.50 (+0.08%)
     
  • Dow Futures

    34,472.00
    +30.00 (+0.09%)
     
  • Nasdaq Futures

    13,612.25
    +14.50 (+0.11%)
     
  • Russell 2000 Futures

    2,245.60
    +5.70 (+0.25%)
     
  • Crude Oil

    64.67
    -0.04 (-0.06%)
     
  • Gold

    1,820.60
    +4.90 (+0.27%)
     
  • Silver

    27.42
    -0.05 (-0.19%)
     
  • EUR/USD

    1.2088
    +0.0019 (+0.16%)
     
  • 10-Yr Bond

    1.5610
    0.0000 (0.00%)
     
  • Vix

    18.38
    -0.77 (-4.02%)
     
  • GBP/USD

    1.3916
    +0.0024 (+0.17%)
     
  • USD/JPY

    109.1110
    +0.0260 (+0.02%)
     
  • BTC-USD

    56,144.24
    -715.76 (-1.26%)
     
  • CMC Crypto 200

    1,464.14
    -7.27 (-0.49%)
     
  • FTSE 100

    7,114.89
    +38.72 (+0.55%)
     
  • Nikkei 225

    29,357.82
    +26.45 (+0.09%)
     

PRESS DIGEST- Financial Times - March 30

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

March 30 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.

Headlines

Biden urged to 'desist' from threat of tariff war with UK https://on.ft.com/39s71nP

Suez Canal ship finally free in boost for global trade https://on.ft.com/3waXTh5

GSK to help manufacture 60m doses of Novavax Covid vaccine in UK https://on.ft.com/2QEyxb5

Overview

Britain has urged U.S. President Joe Biden to back away from a tit-for-tat tariff war over Britain's imposition of a "digital services tax" that will hit Silicon Valley tech companies.

The skyscraper-sized container ship that has been stuck in the Suez Canal for almost a week was finally freed on Monday, with the vessel starting to move north following a dramatic rescue mission to reopen one of the world's main trade arteries.

British drugmaker GlaxoSmithKline Plc will be part of the manufacturing process for up to 60 million doses of the COVID-19 vaccine developed by U.S. rival Novavax Inc in an agreement set to boost UK production of coronavirus jabs. (Compiled by Bengaluru newsroom)